Physician profile
Abel Murillo
NPI 1063490852
$2,480.03
in general payments reported to CMS, 2019-2025
30 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $38.02 · 2021: $251 · 2022: $462 · 2023: $742 · 2024: $238 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833 · Travel and Lodging: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.87 |
| Travel and Lodging | $305.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $631.44 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $339.70 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $229.03 | 2019-2022 | |
| Abbott Laboratories | $194.34 | 2020-2023 | Proclaim |
| Nevro Corp. | $184.95 | 2019-2024 | Senza |
| Medtronic, INC. | $171.44 | 2024-2025 | Synchromedii, Intellis Adaptivestim |
| Painteq LLC | $162.90 | 2024 | Painteq |
| Boston Scientific Corporation | $133.44 | 2019-2025 | General - Pain Management |
| Akebia Therapeutics INC | $131.72 | 2019 | |
| Nalu Medical, INC. | $61.93 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $56.86 | 2022 | |
| Medtronic USA, INC. | $29.45 | 2019 | |
| Grt US Holding, INC. | $26.37 | 2022 | |
| Depuy Synthes Sales INC. | $26.07 | 2023 | Matrixmidface |
| Si-Bone, INC. | $19.36 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $18.89 | 2023 | Tirosint, Licart |
| Kci USA, INC. | $18.42 | 2020 | |
| Forte Bio-Pharma LLC | $14.95 | 2024 | Prolate, Nalocet |
| Kaleo, INC. | $14.88 | 2019 | |
| Biodelivery Sciences International, INC. | $13.89 | 2019 |
10 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abel Murillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.